Status:
COMPLETED
The MuSt-PC: a Pilot Study to Assess Symptom Burden of Co-occuring Symptoms
Lead Sponsor:
University Medical Center Groningen
Collaborating Sponsors:
Leiden University Medical Center
Conditions:
Palliative Care
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this pilot study, physicians and nurse practitioners working in different care settings will use MuSt-PC, for adult patients with any life-limiting iilness, for whom the Surprise question is answer...
Detailed Description
In this pilot study, physicians and nurse practitioners working in different care settings will use MuSt-PC, for adult patients with any life-limiting iilness, for whom the Surprise question is answer...
Eligibility Criteria
Inclusion
- Patients identified as in a palliative care trajectory (based on a negative answer to the surprise question "Would I be surprised if this patiënt died in the next 12 months?")
- All primary diseases (cancer, non-cancer (e.g. COPD, haart failure, frailty)
- Patients should have at least two symptoms on the Utrecht Symptom Diary with a numeric rating score of 4 or higher
- Life expectancy of at least 4 weeks
- Able to fill out Dutch questionnaires
- Informed consent
Exclusion
- Patients who are unable or unwilling to self-assess their symptoms at baseline.
Key Trial Info
Start Date :
April 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2025
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06107946
Start Date
April 18 2024
End Date
February 28 2025
Last Update
November 25 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Groningen
Groningen, Netherlands
2
LUMC
Leiden, Netherlands